IVERMECTIN is better than any allergy pill as it is long acting - Testimonial from a Canadian nurse who grew up with Ivermectin

By Editorial Team -
Incredible story from a Canadian nurse who grew up on a grain and cattle farm and handled Ivermectin all her life. 



Source: Dr William Makis (X/Twitter)

Comments

Post a Comment

Labels

Show more

Archive

Show more

Popular posts from this blog

Ivermectin and Fenbendazole: Treating Turbo Cancer - Dr William Makis

By Editorial Team -
Image
Ivermectin Resources Recently, I have seen tremendous demand for some sort of initial guidance “WHERE TO START” with High Dose Ivermectin for CANCER. Editor's Note: Dr Makis proposes four distinct cancer protocols for using Ivermectin in cancer treatment, specifically for patients who have developed turbo cancer or aggressive cancers. These protocols, referred to as the “Dr. Makis Ivermectin Cancer Protocols,” are categorized based on dosage and the severity of the cancer. Updated version I have an article and a video that go into depth: June 10, 2024 - "15 minutes with Dr.Makis" - Episode 018: High Dose Ivermectin and Cancer .  2025 studies on ivermectin for cancer Yuan Yuan et al (Cedars-Sinai Medical Center) - A phase I/II study evaluating the safety and efficacy of ivermectin in combination with balstilimab in patients with metastatic triple negative breast cancer (ASCO 2025) Yuwen et al -  A Review of Ivermectin Use in Cancer Patients: Is it Time to Repurpose the Ive...
Read more

Fenbendazole Cancer Success Stories: 230 Case Reports Compilation (September 2025 Edition)

By Editorial Team -
Image
Table of Contents: Editor's Preface Introduction Fenbendazole Case Series Compilation (alphabetical) Breast Cancer Success Stories  (45 cases) Brain Cancer (including Glioblastoma) (7 cases) Bile Duct Cancer (Cholangiocarcinoma) Bladder Cancer Success Stories (7 cases) Cervical Cancer  (2 cases) Colorectal Cancer  (29 cases) Esophageal and Stomach cancer (9 cases) Endometrial Cancer (6 cases) Gastric (Stomach) cancer (refer to Esophageal and Stomach Cancer ) Head and Neck Cancer (12 cases) Kidney Cancer Case Series (12 cases) Liver Cancer (HepatoCellular Cancer)  (3 cases) Lung Cancer (20 cases) Leukemia (2 cases) Lymphoma (10 cases) Melanoma (refer to Skin Cancer ) Multiple Myeloma (2 cases) Myelodysplastic Syndrome Oral Cancer Ovarian Cancer  (5 cases) Pancreatic Cancer  (23 cases) Pro...
Read more

Ivermectin, Fenbendazole and Mebendazole in Cancer: 2024 Peer-Reviewed Protocol in Cancer

By Editorial Team -
Image
We are pleased to announce that the first-of-its-kind protocol utilizing Ivermectin, Mebendazole, and Fenbendazole for cancer treatment has been peer-reviewed and officially published on September 19, 2024. Spearheaded by leading researchers like Dr. Ilyes Baghli, Dr. Pierrick Martinez, and the FLCCC’s Dr. Paul Marik, this groundbreaking protocol harnesses the untapped power of Ivermectin, Mebendazole, and Fenbendazole, known for their effectiveness against parasites. Now, these drugs are showing potential to battle cancer, marking the dawn of a new treatment evolution. This trio of repurposed drugs has been shown to disrupt the growth of cancer cells, particularly by targeting microtubules, the essential structures that allow cancer to multiply uncontrollably. What makes this protocol even more potent is the synergistic effect when these drugs are used together, creating a powerful new affordable weapon against cancer. Journal of Orthomolecular Medicine 2024 Targeting the Mitochondri...
Read more

Fenbendazole Joe Tippens Protocol: A Step-by-Step Guide (2025)

By Editorial Team -
Image
If you have been diagnosed with cancer, or have a loved one that is suffering from cancer, chances are you have heard about the Joe Tippens Cancer Protocol. The Fenbendazole Cancer Protocol has been gaining rapid interest over the past years following some fenbendazole advanced cancer success stories . We have seen tremendous demand for some sort of guide on how to use fenbendazole for cancer as there is also tremendous confusion both from the healthcare and non-healthcare communities. Joe Tippens founded the protocol (1) after he was told a story about a scientist at Merck Animal Health that had been performing cancer research on mice. The research included injecting different types of cancers into different mice body parts. The scientists discovered, through trial and error, a product in their canine product line, fenbendazole, that was batting 1.000 in killing these different cancers in the mice. The scientist was later diagnosed with ...
Read more

Best Ivermectin Dosage for Humans with Cancer or Different Cancer Types (2025)

By Editorial Team -
Image
Introduction This article discusses dosage considerations and key factors regarding the use of ivermectin in cancer treatment. Commonly available information about ivermectin dosages is often inaccurate when applied to potential cancer-related uses.  Many sources cite standard dosages recommended by Merck for treating parasitic infections, rather than dosages studied specifically in the context of cancer research. The anti-parasitic dosage is not as effective for people looking for a dosage against cancer. Dosage will need to be adjusted according to cancer type and stage. Ivermectin dosage should be based on ivermectin cancer studies. Multiple factors are considered including studies including ivermectin for cancer, anecdotal studies and case series, the aggressiveness of the cancer type and the cancer stage. Cancer dosage estimation can be adjusted based on the time that a person has to beat cancer or its risk to the patient - this includes both the cancer type and whether the ca...
Read more

Ivermectin Tested against 28 types of Cancer: Most Sensitive vs Least Sensitive

By Editorial Team -
Image
A research group from Mexico investigated Ivermectin in Cancer. This is the first study that has tested as many as 28 Cancer types with Ivermectin.  Paper: 2020 (Juarez et al) - Antitumor effects of ivermectin at clinically feasible concentrations support its clinical development as a repositioned cancer drug.  Ivermectin was tested at 2mg/kg/day which translates to roughly 5uM in vitro concentration. The most sensitive cancer cell lines were: 1. Ovarian 2. Breast 3. Glioblastoma 4. Lung Cancer 5. Colon Cancer 6. Uterine SCC 7. hepatocellular 8. breast TNBC 9. Pancreatic 10. Endometrial. Least sensitive were: 1. osteosarcoma 2. gastric 3. melanoma  Although lymphoma and leukemia cell lines appear to be more resistant to Ivermectin, Ivermectin has a significant impact on those cells' ability to form colonies. So yes, Ivermectin is useful against BOTH lymphomas and leukemias.  Ivermectin also goes after CANCER STEM CELLS, which tend to be resistant to chemotherapy: ...
Read more

DMSO 101: Benefits, Uses, Dosage and Side Effects (2025)

By Editorial Team -
Image
In 2022, Erica Eyres, a vigorous fifty-six-year-old aerobics instructor who had struggled to breathe, was given “absolutely devastating” news: She might need a lung transplant. She had never smoked, ran cross-country track in high school, and was a personal trainer for years, but, by 2024, a transplant assessment was arranged. (1) “I decided that I will make that decision,” she said, “only if it’s the last resort, and I’m on my deathbed.” A few months before her consultation, however, Eyres, then fifty-eight, made an appointment with a new primary care doctor for routine prescription refills. She was about to be introduced, literally and figuratively, to a new kind of medicine. It would change everything. Dr. James Miller, a former surgeon, liked to get to know his patients, so he asked Eyres for her history. She told him of her diagnosis, thirty years prior, with a serious but manageable case of scleroderma. In 2020, however, this auto-immune disorder, which can affect skin and organs...
Read more

Best Fenbendazole Dosage for Humans: Safety, Side Effects and Efficacy Examined (2025)

By Editorial Team -
Image
Fenbendazole is a broad spectrum anti-parasitic used against gastrointestinal parasites including: giardia, roundworms, hookworms, whipworms, the tapeworm genus Taenia (but not effective against Dipylidium caninum, a common dog tapeworm), pinworms, aelurostrongylus, paragonimiasis, strongyles, and strongyloides that can be administered to sheep, cattle, horses, fish, dogs, cats, rabbits, most reptiles, freshwater shrimp tanks as planaria and hydra treatments, as well as seals. (1) Fenbendazole, has garnered ⁤attention​ for its potential use ​in‍ humans.‍ The Fenbendazole Cancer Protocol gained rapid interest over the past years following some fenbendazole advanced cancer success stories . Joe Tippens founded the protocol  after he was told a story about a scientist at Merck Animal Health that had been performing cancer research on mice. The research included injecting different types of cancers into different mice body parts. The scientists...
Read more

Fenbendazole and Ivermectin for Prostate Cancer Success Stories: 33 Case Reports Compilation (September 2025 Edition)

By Editorial Team -
Image
Introduction Prostate cancer remains a significant health challenge globally, particularly in its advanced stages where treatment resistance and disease progression limit patient outcomes. Despite advances in targeted therapies, hormone therapies, and immunotherapies, many patients with metastatic or recurrent prostate cancer face a need for new, more effective treatment options. Enzalutamide and abiraterone are used to treat various subtypes of prostate cancer, with testing and monitoring tailored to each specific subtype. The primary subtypes treated with these agents are metastatic hormone-sensitive prostate cancer (mHSPC) and metastatic castration-resistant prostate cancer (mCRPC). Androgen Receptor (AR) splice variant (AR-V7) is a specialized test for circulating tumor cells (CTCs) to detect the AR-V7 mutation, a known mechanism of resistance to enzalutamide. However, treatment options remain limited for patients with other subtypes of stage 4 prostate cancer, par...
Read more

Fenbendazole, Ivermectin and Mebendazole for Breast Cancer Success Stories: 45 Case Reports (September 2025)

By Editorial Team -
Image
Breast cancer remains one of the most challenging and prevalent malignancies worldwide, with metastatic and treatment-resistant cases posing significant therapeutic hurdles. Conventional treatment options, including chemotherapy, targeted therapies, and immunotherapy, often reach their limits, particularly in advanced stages such as triple-negative breast cancer (TNBC).  For patients with actionable mutations identified through molecular profiling, targeted therapies are the preferred treatment approach. In particular, for estrogen receptor–positive (ER+) breast cancer patients with a low Oncotype DX recurrence score, hormonal therapy alone is often appropriate, as genomic testing indicates a low risk of cancer recurrence and supports de-escalation of more aggressive systemic treatments. The preference for targeted treatments reflects their demonstrated efficacy in improving outcomes in these molecularly defined subgroups, underscoring the importance of comprehensive genomic profil...
Read more